mSOAR and Early Mortality in Acute Stroke
ConditionAcute Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSohag University
About this trial
This observational study aims to evaluate the predictive accuracy of the Modified SOAR score for early mortality in patients with acute stroke. Adult patients presenting with acute stroke at Sohag University Hospitals will be included. Data on clinical presentation, medical history, and relevant laboratory investigations will be collected. The study will follow patients during their hospital stay to determine outcomes related to early mortality. The findings will help improve early risk stratification and management of acute stroke patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients diagnosed with acute stroke
Patients admitted to Sohag University Hospitals
Patients who underwent clinical evaluation
Patients who provided informed consent
Disqualifiers
Patients with transient ischemic attack (TIA)
Patients with orthopedic conditions
Trial population
The study population includes patients diagnosed with acute stroke who are admitted to Sohag University Hospitals. Patients must present within 24 hours of symptom onset and provide informed consent. This cohort will include both male and female patients, and patients with complete medical records necessary for calculating the Modified SOAR score.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
No Intervention (Observational Study)
Other interventionParticipants will receive standard of care only. No study-specific intervention is applied.
Treatment groups
60 Participants
are divided into 1 treatment groupGroup A: Acute Stroke Patients1 intervention
Trial outcomes
Primary outcomes
1
Early Mortality
Assessment of early mortality in patients with acute stroke during the follow-up period.
Time frame
7days2
Early mortality
Assessment of early mortality in patients with acute stroke during the first 7 days of hospital admission. Patients will be monitored from hospital admission until 7 days or until death, whichever occurs first. The Modified SOAR score will be recorded for each patient at admission to evaluate its predictive accuracy for early mortality within this period.
Time frame
7 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov